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Correspondecondhand tobacco smoke (SHS) is an environmental toxin and an established cause of cardiovascular
disease in nonsmokers. Smoke-free laws reduce SHS and its downstream cardiovascular disease, but until
recently, evidence to support smoke-free law implementation in low- and middle-income country set-
tings was limited. In 14 low- and middle-income nations surveyed by the Global Adult Tobacco Survey,
active smoking prevalence in adults (P15 years old) was universally higher in men (range 21.6–60.2%)
than in women (0.5–24.4%), and the highest burden of SHS exposure was in women (strong positive
association between male/female active smoking ratio and female SHS exposure prevalence). A system-
atic review was conducted of MEDLINE-indexed studies of self-reported SHS exposure and cardiovascular
harms in low- or middle-income nations. Eight papers reported the association of SHS with ischemic
heart disease, and four reported the association of SHS with stroke. For all the studies, and almost all
sources of SHS surveyed, a strong positive association between SHS and ischemic heart disease (main
relative odds ratio range 1.17–2.36) and SHS and stroke (odds ratio or hazard ratio: 1.41–1.49). Prevalence
of SHS exposure is high in low- and middle-income nations, especially among women. Epidemiologic
evidence supports the conclusion that SHS harms are the same across low-, middle-, and high-income
nations. Governments have an obligation to protect citizens from SHS exposure, enforcing smoke-free
legislation and providing public education about SHS harms.Involuntary exposure to secondhand tobacco
smoke (SHS) increases the risk of ischemic heart
disease (IHD) and lung cancer in nonsmoking
adults and likely increases stroke risk [1,2].
Reduced myocardial infarction rates after imple-
mentation of smoke-free policies in specific
jurisdictions support the hypothesis that IHD
risk declines rapidly when SHS exposures are
reduced [3]. Therefore, SHS is a cause of cardio-
vascular disease (CVD) preventable by public
health policy.Department of Sociology, New York University, New York, NY, U
Medical Center, New York, NY, USA; §Department of Onco
ence: A. Moran (aem35@columbia.edu).Most past studies of the public health burden
attributable to tobacco smoking have underesti-
mated tobacco’s contribution to global morbidity
and mortality by neglecting SHS [4,5]. Likewise,
past tobacco-control policy analyses have often
underestimated the policy impact of workplace
and public space smoking bans by projecting reduc-
tions in active smoking exposures alone [6–9].
One in 10 CVD deaths are attributable to active
smoking, and approximately 40% of the global
tobacco-related CVD burden is borne bySA; Division of General Medicine, Department of Medicine, Columbia
logy, Georgetown University Medical Center, Washington, DC, USA.
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many of the low- and middle-income nations have
high male smoking rates, but substantially lower fe-
male rates so that nonsmoking women may be
more likely to be exposed in the home. A 2010
study of the burden of disease attributable to
SHS in 192 countries estimated that 603,000
deaths, including 379,000 IHD deaths and 1% of
global mortality were due to SHS exposures in
2004 [10]. That study relied on incomplete expo-
sure data in adults and SHS effects on IHD esti-
mated mostly from high-income nation studies,
gaps filled in part by recent publication exposure
estimates from the Global Adult Tobacco Survey
(GATS) [11], and recent epidemiologic studies of
the association between SHS and IHD and stroke
in low- and middle-income nations [12–18].
Smoke-free laws are a cornerstone policy arm of
global tobacco-control policy, incorporated in the
World Health Organization (WHO) Framework
Convention for Tobacco Control [19]. In this pa-
per, we review adult SHS prevalence data from
the GATS and studies of SHS and CVD in low-
and middle-income nations in order to present
the case for preventing CVD by implementing
smoke-free laws worldwide. We present evidence
that SHS is an important public health problem
in low- and middle-income nations, where women
are often the main ‘‘innocent victims’’ of SHS.P R EVA L ENC E OF S E CONDHAND SMOKE
E X POSUR E S I N LOW - AND M IDD L E -
I N COME NAT I ON S : T H E G LOBA L ADU L T
TOBACCO SURV E Y
In the United States, in 2010, 19.3% of adults
P18 years were active smokers [20]. When a sen-
sitive biomarker such as serum cotinine P5 ng/ml
was used to define SHS exposure, approximately
37% of U.S. adults were estimated to be exposed
to SHS (prevalence was higher in ages <20 years,
the poor, and African Americans) [21]. However,
SHS exposure has declined along with active
smoking in high-income nations [21].
Active smoking declines have not been repli-
cated in many low- and middle-income nations,
and until recently, SHS prevalence was unknown
in these nations. In 2007, WHO sponsored the
nationally representative GATS in 16 low- and
middle-income nations (Bangladesh, Brazil, China,
Egypt, India, Indonesia, Mexico, Pakistan, Philip-
pines, Poland, Russian Federation, Thailand, Tur-
key, Ukraine, Uruguay, and Vietnam). Data fromonly 14 sites were available for this review (Pakistan
and Indonesia data not available) [11]. GATS
comprised multistage stratified samples of urban
and rural men and womenP15 years of age in each
country. Prevalence of self-reported active smoking
and SHS exposures were weighted in order to pro-
vide nationally representative estimates (Table 1,
Supplemental Table 1). Most countries elicited
self-reported public place SHS exposure among
persons visiting those places within the prior
30 days.
Active smoking prevalence was higher in men
than in women in all the GATS nations, but home
SHS exposures were common in men and women
alike (Table 1, Supplemental Table 1). Though
the exposure denominator in Table 1 was smokers
and nonsmokers, a similar prevalence was found in
nonsmokers (Supplemental Table 2). The GATS
nations with the lowest levels of SHS have the
most active tobacco-control policies (Brazil, Mex-
ico, Thailand, and Uruguay). The nations listed
as having smoke-free legislation have expanded
the scope of their laws to cover more public spaces
since GATS was conducted [22].
Male active smoking was the driver of female
SHS exposures at home or at work, especially in
countries with high male and low female active
smoking prevalence (high male/female active
smoking ratios) (Figs. 1 and 2). The same strong
association between male/female active smoking
ratio and SHS among female nonsmokers was ob-
served in the nations reporting SHS exposures in
nonsmokers only (Supplemental Fig. 1). Variability
in female SHS among nations with similar male/
female ratios, such as Mexico and Turkey, could
be explained by different male smoking patterns,
relatively higher rates of both male and female
smoking in some nations (e.g., Turkey), or SHS
under- or over-reporting.HOW DOE S SH S CAU S E CVD ?
SHS is also known as environmental tobacco
smoke or passive smoking. SHS is a combination
of mainstream smoke exhaled by active smokers
and side stream smoke given off by smoldering cig-
arettes or other smoked tobacco sources. Human
subjects studies have documented that SHS expo-
sure leads to both acute and chronic damage to
the cardiovascular system. Acutely, SHS causes
platelet activation, causes coronary artery endothe-
lial dysfunction [23,24], and impairs heart rate var-
iability [25] similar to the effects of active smoking
Table 1. Active smoking and prevalence of selected SHS exposures (%) in 14 low- and middle-income nations, the Global Adult
Tobacco Survey, 2007–2009 [11]. Smoke-free workplace or public space laws status obtained from the 2011 World Health
Organization, Tobacco Control Country Proﬁles report (reporting on laws as of December 31, 2010) [22]
SHS exposures among those visiting these places
Active smoking Home Workplace Restaurants
Bangladesh
Smoke-free laws No No
Men 44.7 N/A 67.8 53.4
Women 1.5 N/A 30.4 2.2
Brazil
Smoke-free laws Yes Yes
Men 21.6 28.9 28.5 
Women 13.1 27 20.4 
China
Smoke-free laws§ No No
Men 52.9 70.5 71.1 91.8
Women 2.4 63.9 53.2 83.3
Egypt
Smoke-free laws Yes No
Men 37.7 82.5 62.4 75.6
Women 0.5 80.5 54 62.1
India
Smoke-free laws Yes No
Men 24.3 52.2 32.2 19.2
Women 2.9 52.5 19.4 2.8
Mexico
Smoke-free laws– Yes Yes
Men 24.8 17.2 23.3 30.9
Women 7.8 17.4 13.9 28.1
Philippines
Smoke-free laws No No
Men 47.7 58.1 43.3 38.3
Women 9.0 50.6 28.8 28.6
Poland
Smoke-free laws No No
Men 36.9 44.9 41.3 53.4
Women 24.4 43.6 24.9 54.3
Russian Federation
Smoke-free laws No No
Men 60.2 36.7 45.7 78.3
Women 21.7 33.0 25.7 78.8
Thailand
Smoke-free laws Yes Yes
Men 45.6 43.4k 34.9 
Women 3.1 35.1k 18.9 
Turkey
Smoke-free laws Yes Yes
Men 47.9 56.1 41.5 57.7
Women 15.2 56.5 28.3 52.3
(continued on next page)
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Table 1. continued
SHS exposures among those visiting these places
Active smoking Home Workplace Restaurants
Uruguay
Smoke-free laws Yes Yes
Men 30.7 32.0k 21.4 N/A
Women 19.8 26.7k 11.8 N/A
Vietnam
Smoke-free laws Yes No
Men 47.4 77.2 68.7 90.9
Women 1.4 69.2 41.4 75.2
N/A, not available; SHS, secondhand smoke.
 Brazil did not have a national smoke-free policy, but does have complete smoke-free legislation in seven jurisdictions that
govern almost 40% of the national population: Amazonas, Paraiba, Parana, Rio de Janeiro, Rondonia, Roraima, and Sao Paolo.
 Brazil and Thailand reported public place SHS exposures using total adult population as the denominator (unlike the
other countries in this table that used population visiting the selected public place in the prior 30 days as the denominator).
See Supplemental Table 3 for the Brazil and Thailand data using total population as the denominator.
§ The exception for China is that the Hong Kong Administrative Region had comprehensive smoke-free laws.
– Mexico City and Tabasco had comprehensive smoke-free laws (covering 4% of Mexico’s population).
k Thailand and Uruguay did not use the same monthly threshold for measuring exposure in the home as the other countries
did. Thailand included exposure that occurs less than monthly, and Uruguay reported exposure that occurs at least weekly.
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rial stiffness [26,27] and atherosclerosis progression
[28], perhaps mediated by raised and oxidized low-
density lipoprotein cholesterol [29], lowered high-
density lipoprotein cholesterol [30], and increased
inflammatory response [31]. The pathological effects
of SHS occur abruptly at low exposure levels––there
is no ‘‘safe’’ level of passive smoke exposure [1,23,32].Viet
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155cohort studies with long-term follow-up. A prob-
lem specific to SHS is misclassification bias: most
epidemiologic studies are based on self-reported
SHS exposure, which could lead to under- or
over-reporting exposure duration or intensity.
However, under-reporting has likely been more
common, because background involuntary second-
hand exposure has been common in the past. This
leads to misclassifying SHS exposed individuals as
‘‘nonexposed’’ and biasing hazard estimates toward
the null (or ‘‘no harm’’).
The 2006 U.S. Surgeon General’s report [1]
summarized the evidence of SHS effect on CVD
by reviewing prior meta-analyses and pooling esti-
mates from original observational studies. Of the
19 studies pooled, all were based on self-reported
SHS exposure. The overall relative risk of coronary
heart disease in nonsmokers exposed to SHS was
1.26 (95% confidence interval [CI]: 1.19–1.36)
compared with unexposed nonsmokers. The rela-
tive hazard estimate did not vary substantially
according to sex, exposure location, or study type
(case control vs. cohort). The pooled relative risk
estimate for studies that adjusted for other IHD
risk factors was higher than the estimate for unad-
justed studies. Analysis restricted to studies quanti-
fying exposure intensity (number of actively
smoked cigarettes exposed to daily) suggested a
dose–response relationship between SHS and
IHD risk. Only 6 studies of secondhand smokingand stroke were reviewed by the Surgeon General’s
report. Exposure measurement, adjustment for
confounders, and definitions of stroke varied
among the studies. Two studies showed a statisti-
cally significant association between secondhand
smoking and stroke; other studies produced esti-
mates with 95% confidence intervals that crossed
the null (i.e., included the possibility of no harm).
The 2006 report concluded that causal evidence for
the link between SHS and IHD was ‘‘sufficient,’’
but evidence of a causal link between SHS and
stroke was ‘‘suggestive, but not sufficient.’’ A num-
ber of stroke and SHS epidemiology studies have
been completed since the Surgeon General’s report
review. Oono et al. [33] reviewed 20 stroke studies
in 2011 and found a pooled relative risk of 1.25
(95% CI: 1.12–1.38) and evidence of a dose–re-
sponse relationship for the association of stroke
with SHS.
How might misclassification bias have affected
the IHD relative risk estimate from the Surgeon
General’s report and other estimates based on
self-reported SHS exposure? One solution to the
problem of misclassification resulting from self-
reporting of SHS exposure has been to measure
exposure using serum or salivary cotinine levels ob-
tained from nonsmokers. Cotinine is the principal
metabolite of nicotine and is a sensitive and specific
biomarker of SHS exposure in nonsmokers [34].
Whincup et al. [35] studied the association of
156 Olasky et al.
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of 0.8–14.0 ng/ml categorized as ‘‘exposed’’ and
67 ng/ml categorized as ‘‘unexposed.’’ Defined as
having elevated baseline cotinine, SHS had a rela-
tive risk of IHD of 3.73 (95% CI: 1.32–10.58) dur-
ing the first 4 years of follow-up, a relative risk of
1.95 (95% CI: 1.09–3.48) in years 5–9, and the risk
continued to decline toward the null after 20 years
of follow-up (because baseline exposure measure-
ment represented future exposure less and less over
time or because of a secular trend toward less active
smoking in Britain). The effect remained signifi-
cant after adjustment for other IHD risk factors
and showed a (cotinine) dose–response relation-
ship. No significant association was found between
stroke and SHS. The Whincup study demonstrates
an IHD relative risk affect size related to SHS that
is substantially higher when misclassification bias is
eliminated.
Little is known about CVD risk associated with
SHS in low- and middle-income countries (e.g.,
the U.S. Surgeon General’s 2006 meta-analysis
[1] included an IHD study from Argentina [36]
and another from China [37]), and whether the
association differs in these populations. Though
biological effects of SHS are likely the same in all
people, quality of building ventilation and use of
air conditioning may differ. Also, levels of indoor
air pollution from solid fuel combustion (e.g., in-
door cooking or heating fires) are high in some
low- and middle-income nations. To evaluate epi-
demiologic evidence related to SHS and CVD in
low- and middle-income nations, we conducted a
systematic review of epidemiologic studies of
SHS and risk for CVD using MEDLINE (via
PubMed) and restricting the search to low- and
middle-income country studies that gathered
SHS exposure information and reported SHS asso-
ciation with a cardiovascular outcome ascertained
using standard diagnostic criteria (Supplemental
Methods). Across the 10 included studies, self-
reported spousal or total household home SHS
exposure was most commonly reported and were
most comparable to past reviews [1,2], so those
exposure types were compared (Table 2). We found
no low- or middle-income studies that used cotinine
or other biomarkers to assess SHS exposure.
The eight studies from low- or middle-income
nations reporting on IHD were case controlled,
and for most, the outcome was nonfatal IHD (be-
cause cases were expected to report on SHS expo-
sure history). All main odds ratios were above
1.00, only two estimates included 1.00 in the lower95% CI bound [15,16], and no lower bound ex-
ceeded the upper bound of the Surgeon General re-
port’s meta-analysis [1] 95% CI (upper limit of
relative risk: 1.36). The INTERHEART (A Study
of Risk Factors for First Myocardial Infarction in
52 Countries and Over 27,000 Subjects) was an
international case–control study of myocardial
infarction in which approximately 80% of partici-
pants were from low- and middle-income coun-
tries. The increased odds of myocardial infarction
associated with spousal active smoking in INTER-
HEART overall was 1.28 (odds ratio; 95% CI:
1.12–1.47) [38].
Four studies reporting on SHS and stroke in
low- or middle-income nations have been pub-
lished since the Surgeon General’s 2006 report
[1]. One cohort––the Shanghai Women’s Health
Study––provided data for both a case-control study
[17] and a cohort study [18] (Table 2). A strong
positive association between household SHS expo-
sure and total stroke was found in all studies. Of
note, follow-up of the Shanghai Women’s Health
Study cohort found no significant association be-
tween workplace exposure and stroke [hazard ratio:
0.73 (95% CI: 0.44–1.02)] [18], though this esti-
mate may have been affected by insufficient fol-
low-up time or exposure misclassification bias.SMOK E F R E E L AWS R EDUC E I HD RA T E S
I N NONSMOKE R S : E V I D ENC E F ROM
POL I C Y ‘ ‘ NA TURA L E X P E R IM ENT S ’ ’
Without a policy intervention, SHS exposures may
track downward if active smoking declines and
societal attitudes toward indoor smoking change,
but these mechanisms for an SHS decline are slow
and by no means guaranteed. Smoke-free laws re-
duce SHS exposure quickly. Smoke-free laws also
reduce active smoking prevalence approximately
15% among active smokers and reduce the number
of cigarettes smoked daily [39,40]. After a smoke-
free workplace legislation in Finland (1995),
California (1998), New York (2002), the Republic
of Ireland (2004), Scotland (2004), France (2007–
2008), and smaller jurisdictions in Colorado,
Montana, Canada, and Italy, SHS exposures were
reduced dramatically within 5-year periods in
workers surveyed before and after the bans [3,41].
A carbon dioxide measurement study demonstrated
the effectiveness of a restaurant, bar, and nightclub
smoking ban in reducing SHS levels in Sao Paulo,
Brazil [42]. Because of the difficulty of accurately
Table 2. Epidemiologic studies of the association of SHS exposure with CVD in low- or middle-income nations
CVD type and study Nation Study type Observation years Population Exposure Outcome Effect
measure
Effect Size Controlled
for CVD
risk factors
Dose-response
pattern
Start End Cohort or cases (if case control) Control subjects Main Lower Upper
IHD
He et al. (1989) [46] China Case control Unreported 34 female nonsmokers: hospital-
based
68 female nonsmokers: 34
hospital-based, 34 population-
based
Spouse smoked Nonfatal IHD Odds ratio 1.50 1.28 1.77 Yes Yes
He et al. (1994) [37] China Case control 1989 1992 59 female never smokers
diagnosed with IHD, employed
full-time, hospital-based
126 female never smokers,
employed full-time, hospital- and
community-based
Spousal or
workplace exposure
Nonfatal IHD Odds ratio 2.36 1.01 5.55 Yes Yes
McGhee et al.
(2005) [12]
China (Hong
Kong)
Case control 1988 1998 584 IHD deaths in persons age
P60 years from death registries
763 living contemporaries age
P60 years giving information at
the same time
Smoker in the
household
IHD death Odds ratio 1.35 1.03 1.76 No Yes
He et al. (2008) [13] China Case control 2001 2002 431 female never smokers aged
60 years or older, population-
based
778 female never smokers aged
60 years or older, population-
based
Home or workplace Nonfatal IHD Odds ratio 1.69 1.31 2.18 Yes§ Yes
Ding et al. (2009)
[14]
China (Hong
Kong)
Case control 2004 2007 314 female never smokers with
IHD, hospital-based
319 female never smokers,
hospital-based
Household Nonfatal IHD Odds ratio 1.52 1.01 2.27 Yes– Yes
Ciruzzi et al. (1998)
[36]
Argentina Case control 1991 1994 336 never smokers with ﬁrst
episode of acute MI, hospital-
based, median age 66 years
446 never smokers, hospital-
based, median age 65 years
Spouse and
children smoked
Nonfatal MI Odds ratio 1.68 1.20 2.37 Yesk Yes
Sulo et al. (2008)
[15]
Albania Case control 2003 2006 169 married never smokers with
acute coronary syndrome, aged
35–74 years, hospital-based
323 married never smokers, aged
35–74 years, population-based
Spouse smoked Nonfatal acute
coronary syndrome
Odds ratio 1.60 0.95 2.70 Yes' No
Rossi et al. (2010)
[16]
Costa Rica Case control 1994 2004 2,094 cases with ﬁrst acute MI,
1,543 men and 551 women,
hospital-based
2,094 control subjects matched
by age, sex, area of residence,
population-based
Smoker in the
household
Acute nonfatal MI Odds ratio 1.17 1.00 1.37 No No
Stroke
McGhee et al.
(2005) [12]
Hong Kong Case control 1988 1998 597 stroke deaths in persons
aged P60 years, from death
registries
763 living contemporaries aged
P60 years, giving information at
the same time
Smoker in the
household
Stroke death Odds ratio 1.49 1.15 1.94 No Yes
Zhang et al. (2005)
[17]
China Case control 1997 2000 526 female married never
smokers reporting stroke history,
aged 40–70 years
59,851 female married never
smokers without stroke history,
aged 40–70 years
Spouse smoked Nonfatal stroke Odds ratio 1.41 1.16 1.72 Yes“ Yes
Wen et al. (2006)
[18]
China Cohort 1997 2004 65,180 female never smokers
aged 40–70 years at baseline,
population-based
Spouse smoking at baseline Stroke death Hazard ratio 1.52 1.08 2.15 No No
He et al. (2008) [13] China Case control 2001 2002 172 female never smokers aged
60 years or older, population-
based
1,037 female never smokers aged
60 years or older, population-
based
Home or workplace Nonfatal stroke Odds ratio 1.65 1.17 2.32 Yes§ Yes
BMI, body mass index; IHD, coronary heart disease; CVD, cardiovascular disease; IHD, ischemic heart disease; MI, myocardial infarction; SHS, secondhand smoke.
 Alcohol consumption; exercise; personal and family history of IHD, hypertension, hyperlipidemia.
 Age, hypertension, personality type, total cholesterol, high-density lipoprotein cholesterol.
§ Age, marital status, education, exercise, alcohol consumption, BMI, systolic blood pressure, total cholesterol, triglyceride levels, history of hypertension and diabetes, family history of IHD/stroke.
– Age, education, hypertension, diabetes, hypercholesterolemia, gout, history of stroke, family history of IHD, physical inactivity, alcohol intake, estrogen use.
|| Age, cholesterolemia, diabetes, hypertension, BMI, education, social status, exercise, family history of MI.
' Age, sex, exercise, hypertension, diabetes, family history of IHD, BMI, waist-to-hip ratio.
“ Age, education, occupation, family income, alcohol consumption, exercise, BMI, menopausal status, hormone therapy, oral contraceptive use, history of hypertension, diabetes, use of antihypertensive medication
or aspirin.
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J u l y 2 0 1 2 : 1 5 1 – 1 6 0 . e 5measuring SHS exposure, and the ethical conflict
involved with randomizing participants to SHS
exposure, the population health benefits of
smoke-free policies have been estimated primarily
based on the ‘‘natural experiments’’ comparing dis-
ease rates in the population before and after smoke-
free policy implementation. Because SHS affects
acute myocardial infarction risk immediately, myo-
cardial infarction rates have been the outcome mea-
sure of most smoke-free policy natural experiments.
A dramatic example occurred in the relatively iso-
lated city of Helena, Montana, in which acute
MI hospitalization rates dropped by approximately
40% during 6 months when a public smoking ban
was in effect and returned to prior levels when
the law was repealed [43]. Lightwood and Glantz
[3] pooled and time-standardized 12 before-and-
after studies of 100% smoke-free public places laws
and found a relative rate of 0.83 (95% CI: 0.80–
0.87) for myocardial infarctions after the bans and
evidence that the benefit appeared to grow for up
to 36 months.D I S CU S S I ON
SHS increases risk for CVD and non-CVD deaths
and disability and may be responsible for 1% of
global mortality, with at least two-thirds of these
deaths due to CVD [10]. The WHO GATS and
Global Youth Tobacco Survey (GYTS) [44]
showed that SHS is common in homes, workplac-
es, and most public places in a geographically and
culturally diverse set of low- and middle-income
nations. Active smoking is much more frequent
in men than in women in many low- and mid-
dle-income nations, and the result is that most
SHS exposures occur in female nonsmokers in
these countries. We found that SHS-associated
CVD risks in the few available low- and middle-
income country epidemiologic studies are similar
to those observed in studies from higher-income
nations. Though not reviewed here, other evidence
supports associations between SHS and increased
risk for lung cancer and a number of other non-
CVDs [1]. Smoke-free laws have been highly
effective public health interventions in high-in-
come nations and should also be effective in low-
and middle-income nations if enforced effectively.
In making the business and policy case for imple-
mentation of the Framework Convention for To-
bacco Control smoke-free policies, the health and
economic development gains from SHS reductionsmust be weighed along with effects on active
smoking.
Data from GATS suggest SHS exposure is
ubiquitous in low- and middle-income nations,
but inconsistencies among the countries beg several
questions that are important to consider in future
surveillance that is important for measuring the
effectiveness of smoke-free policies. How accurate
was self-reported SHS in the GATS surveys?
Exposure self-report questionnaires developed in
the high-income West may not be appropriately
tailored to specific tobacco use patterns and other
contributing social behaviors in low- and middle-
income countries. Also, self-reporting may be
biased by low levels of SHS health risks awareness.
In the Chinese GATS, only 38.7% of respondents
were aware that SHS causes IHD and 27.2% were
aware SHS causes stroke [45]. Given these multi-
ple uncertainties surrounding the GATS SHS esti-
mates, we advocate that future surveillance surveys
and cohort studies employ serum, urine, or salivary
cotinine as a more sensitive and accurate measure of
SHS exposures.
Study questionnaire questions and biomarkers
related to other sources of indoor air pollution
(e.g., indoor solid fuel combustion fumes) should
be added to future studies. The low- and middle-
income nation studies reviewed here mostly sam-
pled urban populations, so more studies of the
interaction between SHS and indoor cooking fire
fumes are needed in rural areas, where solid fuel
combustion is more common.
Smoke-free laws are a cornerstone of the
WHO Framework Convention on Tobacco Con-
trol policy agenda and have been shown to be very
effective, both in limited (e.g., workplace) scope
[41] or as 100% public space bans [3]. Argentina,
Brazil, Mexico, Thailand, Turkey, and Uruguay
are among the low- and middle-income nations
currently pursuing aggressive smoke-free legisla-
tion [22]. Smoke-free laws reduce tobacco harms
from SHS in those unintentionally exposed––in
low- and middle-income nations, predominantly
innocent women and children. Smoke-free policy
is not individual primary prevention as an inter-
vention on 1 patient’s risk factor, but more akin
to an infectious disease public health intervention:
as in treatment for the cure of tuberculosis,
smoke-free laws are likely to improve the
health of the smoker and those around him
‘‘contaminated’’ with SHS. Smoke-free laws are
an expression of a government’s determination to
protect its people’s health and change society’s
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159expectations so that public smoking is viewed as
socially unacceptable.CONC LU S I ON S
Most past estimates of tobacco’s impact on health
underestimated its burden due to lack of consider-
ation of the SHS harms to the public’s health.Governments have an obligation to protect citi-
zens from preventable environmental toxins like
SHS. Governments should not wait for perfect
data from low- and middle-income nations, be-
cause the evidence is sufficient to justify imple-
mentation of smoke-free laws now. Along with
smoke-free laws, public education about SHS
harms is needed, or there may be resistance to
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Electronic search methods. The search terms were
designed to capture all the articles pertaining to
both secondhand smoke (SHS) and cardiovascular
disease (CVD) published during the specified time
period (January 1, 1985, to October 15, 2011) and
confined to studies of low- and middle-income na-
tion populations. The relevant medical subject
headings (MeSH) term included for SHS is ‘‘to-
bacco smoke pollution,’’ and 11 CVD MeSH terms
were included as well. For both subjects, other
commonly used terms were included in the search
parameters to locate articles with those terms in
their title or abstract.
Although the intent was to identify only those
articles pertaining to low- or middle-income coun-
tries, we were unable to create a set of geographical
restrictions that captured all of the relevant articles
identified a priori (articles known to the authors
from the 2006 U.S. Surgeon General’s report and
bibliographies of high-income country publica-
tions). Instead, we placed no geographical restric-
tions on the search, which returned 582 potential
articles. We then screened titles and abstracts of
all of these articles, excluding those that pertained
to high-income nation populations only, did not
include reliable measures of stroke or coronary
heart disease, or were not epidemiological in nat-
ure. We retained 11 full text articles that met the
inclusion criteria. Because the INTERHEART
(A Study of Risk Factors for First MyocardialInfarction in 52 Countries and Over 27,000 Sub-
jects) studied a mix of high-, low-, and middle-in-
come country populations, the SHS-related results
from that study were reported separately in the
manuscript text. We included an additional article
(McGhee et al. [2005]) that our search did not lo-
cate due to the manner in which it was entered into
PubMed, but that we identified through the refer-
ences of other articles.
PubMed search terms: (tobacco smoke pollu-
tion[mesh] OR ‘‘passive smoking’’[tiab] OR ‘‘sec-
ondhand smoke’’[tiab] OR ‘‘second hand smoke’’
[tiab] OR ‘‘environmental tobacco smoke’’[tiab])
AND (‘‘myocardial ischemia’’[tiab] OR: myocar-
dial revascularization’’[tiab] OR ‘‘myocardial reper-
fusion’’[tiab] OR MYOCARDIAL ISCHEMIA/
epidemiology[mesh] OR MYOCARDIAL ISC-
HEMIA/mortality[mesh] OR MYOCARDIAL
REVASCULARIZATION [mesh] OR MYO-
CARDIAL REPERFUSION[mesh] OR ‘‘cardio-
vascular disease’’[tiab] OR CARDIOVASCULAR
DISEASES/epidemiology[mesh] OR ‘‘coronary
disease’’[mesh] OR stroke[mesh] OR stroke[tiab]
OR ‘‘peripheral vascular diseases’’[mesh] OR
‘‘peripheral vascular diseases’’[tiab] OR ‘‘brain
ischemia’’[mesh] OR ‘‘brain ischemia’’[tiab] OR
‘‘myocardial infarction’’[tiab] OR ‘‘coronary heart
disease’’[tiab] OR ‘‘Coronary Artery Disease/
epidemiology’’[mesh] OR ‘‘coronary artery dis-
ease’’[tiab] OR CARDIOVASCULAR DIS-
EASES/mortality[mesh]) AND (‘‘1985/01/
01’’[PDAT]: ‘‘2011/10/15’’[PDAT])
Supplemental Table 1. Active smoking and SHS exposure prevalence (%) in 14 low- and middle-income nations, the Global Adult
Tobacco Survey, 2007–2009 [11]. Smoke-free workplace or public space laws status obtained from the 2011 World Health
Organization Tobacco Control Country Proﬁles report (reporting on laws as of December 31, 2010) [22].
Active
smoking
SHS exposures among those visiting these places
Home Workplace Restaurants Public transit Government
buildings
Healthcare
facilities
Bangladesh
Smoke-free laws No No No No Yes
Men 44.7 N/A 67.8 53.4 35.9 9.2 7.1
Women 1.5 N/A 30.4 2.2 16.9 1.5 4.4
Brazil
Smoke-free laws Yes* Yes* Yes* Yes* Yes*
Men 21.6 28.9 28.5    
Women 13.1 27 20.4    
China
Smoke-free law No No Yes No No
Men 52.9 70.5 71.1 91.8 36.4 62.6 41.2
Women 2.4 63.9 53.2 83.3 31.5 50.7 35.2
Egypt
Smoke-free laws Yes No Yes Yes Yes
Men 37.7 82.5 62.4 75.6 80.3 75.8 53.8
Women 0.5 80.5 54 62.1 78.6 66.7 46.4
India
Smoke-free laws Yes No No Yes Yes
Men 24.3 52.2 32.2 19.2 22 10.3 6
Women 2.9 52.5 19.4 2.8 12.6 2.6 4.8
Mexico
Smoke-free laws§ Yes Yes Yes Yes Yes
Men 24.8 17.2 23.3 30.9 25.4 17.7 5.2
Women 7.8 17.4 13.9 28.1 23.1 16 3.7
Philippines
Smoke-free laws No No Yes Yes Yes
Men 47.7 58.1 43.3 38.3 61.1 27.9 8
Women 9.0 50.6 28.8 28.6 49.7 23.2 7.3
Poland
Smoke free laws No No Yes No No
Men 36.9 44.9 41.3 53.4 10.7 10.7 4.3
Women 24.4 43.6 24.9 54.3 6.6 9.3 4.8
Russian Federation
Smoke-free laws No No No No No
Men 60.2 36.7 45.7 78.3 24.5 21.2 12.1
Women 21.7 33.0 25.7 78.8 25.1 13.8 9.1
(continued on next page)
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Supplemental Table 1. continued
Active
smoking
SHS exposures among those visiting these places
Home Workplace Restaurants Public transit Government
buildings
Healthcare
facilities
Thailand
Smoke-free laws Yes Yes Yes Yes Yes
Men 45.6 43.4|| 34.9    
Women 3.1 35.1|| 18.9    
Turkey
Smoke-free laws Yes Yes Yes Yes Yes
Men 47.9 56.1 41.5 57.7 18.7 13 6.6
Women 15.2 56.5 28.3 52.3 14.1 7.8 5.5
Ukraine
Smoke-free laws No No Yes Yes Yes
Men 50 25.4 44 65.7 17.9 12.9 9.2
Women 11.2 21.9 22.9 62.3 17.2 8.2 5.3
Uruguay
Smoke-free laws Yes Yes Yes Yes Yes
Men 30.7 32.0|| 21.4 N/A N/A N/A N/A
Women 19.8 26.7|| 11.8 N/A N/A N/A N/A
Vietnam
Smoke-free laws Yes No Yes Yes Yes
Men 47.4 77.2 68.7 90.9 38.8 45.4 29.9
Women 1.4 69.2 41.4 75.2 29.6 28.4 19.6
*Brazil does not have a national smoke-free policy, but does have complete smoke-free legislation in seven jurisdictions that govern almost 40% of the national
population: Amazonas, Paraiba, Parana, Rio de Janeiro, Rondonia, Roraima, and Sao Paolo.
Brazil and Thailand reported public place SHS exposures using total adult population as the denominator (unlike the other countries in this table that used population
visiting the selected public place in the prior 30 days as the denominator). See Supplemental Table 3 for the Brazil and Thailand data using total population as the
denominator.
The exception for China is that the Hong Kong Administrative Region was comprehensive smoke-free laws.
§Mexico City and Tabasco have comprehensive smoke-free laws (covering 4% of Mexico’s population).
||Thailand and Uruguay do not use the same monthly threshold for measuring exposure in the home as the other countries do. Thailand includes exposure that occurs
less than monthly, and Uruguay reports exposure that occurs at least weekly.
N/A = not available; SHS = secondhand smoke.
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Supplemental Table 2. SHS exposure prevalence (%) stratiﬁed into all surveyed and nonsmokers (never + past smokers) in
14 low- and middle-income nations, the Global Adult Tobacco Survey, 2007–2009.
SHS Exposure
Home Workplace Restaurant Public transit Government buildings Healthcare facilities
Bangladesh
All N/A 63 27.6 26.3 5.4 5.8
Nonsmokers N/A 75.7 55.4 35.9 9.2 5.8
Brazil
All 27.9 24.4 * * * *
Nonsmokers 22.8 * * * *
China
All 67.3 63.3 88.5 34.1 58.4 37.9
Nonsmokers N/A N/A N/A N/A N/A N/A
Egypt
All 81.5 60.7 72.7 79.6 72.8 49.2
Nonsmokers 78.4 58.5 69.1 80 71.3 47.9
India
All 52.3 29.9 11.3 17.5 6.6 5.4
Nonsmokers 48 26.1 N/A N/A N/A N/A
Mexico
All 17.3 19.7 29.6 24.2 17 4.3
Nonsmokers 14.1 17.7 30.5 23.8 17.4 4.1
Philippines
All 54.4 36.9 33.6 55.3 25.5 7.6
Nonsmokers 44.8 30.8 31.1 53.7 25.1 7.7
Poland
All 44.2 33.6 53.9 8.4 10 4.6
Nonsmokers 28 26.8 50.9 7.4 9.9 4.2
Russian Federation
All 34.7 34.9 78.6 24.9 17 10.2
Nonsmokers 21.5 26.9 72.4 23.9 14.9 8.6
Thailand
All 39.1 27.2 * * * *
Nonsmokers 32.4 23.6 * * * *
Turkey
All 56.3 38.5 55.9 16.5 11.3 6
Nonsmokers 47.5 31.6 50.2 15.7 11.1 5.7
Ukraine
All 23.5 34 64.1 17.5 10.2 6.6
Nonsmokers 14.6 26.6 60.8 16.9 9.4 5.7
Uruguay
All 29.2 16.5 N/A N/A N/A N/A
Nonsmokers N/A N/A N/A N/A
(continued on next page)
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Supplemental Table 2. continued
SHS Exposure
Home Workplace Restaurant Public transit Government buildings Healthcare facilities
Vietnam
All 73.1 55.9 84.9 34.4 38.7 23.6
Nonsmokers 67.6 49 80.7 33.3 34.8 21.6
*Brazil and Thailand reported public place SHS exposures using total adult population as the denominator (unlike the other countries in this table who used population
visiting the selected public place in the prior 30 days as the denominator). See Supplemental Table 3 for the Brazil and Thailand data using total population as the
denominator.
Abbreviations as in Supplemental Table 1.
Supplemental Table 3. SHS exposure prevalence (%) stratiﬁed into all surveyed and nonsmokers (never + past smokers) in
14 low- and middle-income nations, the Global Adult Tobacco Survey, 2007–2009.
SHS exposure of total population
Home Workplace Restaurants Public transit Government buildings Healthcare facilities
Brazil
Smoke-free law No No Yes No No
Men 28.9 28.5 10.8 4.1 3.7 3.0
Women 27.0 20.4 9.0 4.8 3.5 5.0
All 27.9 24.4 9.9 4.5 3.6 4.0
Nonsmokers 22.8 10.1 4.8 3.7 4.1
Thailand
Smoke-free law No No Yes No No
Men 43.4 34.9 10.8 5.1 4.8 2.0
Women 35.1 18.9 7.2 7.5 3.1 2.1
All 39.1 27.2 9.0 6.3 3.9 2.0
Nonsmokers 32.4 23.6 8.8 6.9 3.8 2.2
SHS = secondhand smoke.
Supplemental Fig. 1. Ratio of male/female active smoking and work place secondhand smoke exposure in women in countries
reporting exposures in female nonsmokers, the Global Adult Tobacco Survey, 2007–2009.
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